Abivax announced a temporary trading halt of its ordinary shares on Euronext Paris, effective from the market open at 9:00 a.m. CEST on July 1, 2026. The halt, requested by the company, is to allow for the confirmation of investor allocations and the announcement of pricing for its previously disclosed public offering of American Depositary Shares in the United States. Trading is expected to resume later the same day at approximately 3:30 p.m. CEST, pending a further communication from Abivax.
Abivax SATrading halt and pricing of U.S. offering typically signals dilution, which is negative for existing shareholders.